• This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • #11335
    The University of Cambridge and DIOSynVax chose the PharmaJet System for the study due to its record of increasing the efficacy of nucleic acid-based vaccines and therapeutics.
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.